COX‐2‐selective inhibitors and the risk of upper gastrointestinal bleeding in high‐risk patients with previous gastrointestinal diseases: a population‐based case–control studyBente Mertz Nørgård, Henrik Toft Sørensen|Alimentary Pharmacology & Therapeutics|2004Cited by 56